Nucleic acid encoding a chimeric polypeptide

Details Nucleic acid encoding a chimeric polypeptide Nucleic acid encoding a chimeric polypeptide

2006-10-17

2006-10-17

Zara, Jane (Department: 1635)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S069100, C435S070100, C435S091100, C435S212000, C435S455000, C530S350000, C536S023100, C536S023500, C536S024100

Reexamination Certificate

active

07122354

ABSTRACT:
DNA molecules comprising a sequence encoding the signal peptide of hGH linked to a heterologous protein and related cells, methods and fusion proteins.

REFERENCES:
patent: 4407957 (1983-10-01), Lim
patent: 4740365 (1988-04-01), Yukimatsu et al.
patent: 4764376 (1988-08-01), Hirsch et al.
patent: 5179023 (1993-01-01), Calhoun et al.
patent: 5272066 (1993-12-01), Bergh et al.
patent: 5298400 (1994-03-01), Whitfeld et al.
patent: 5356804 (1994-10-01), Desnick et al.
patent: 5401650 (1995-03-01), Desnick et al.
patent: 5654007 (1997-08-01), Johnson et al.
patent: 5658567 (1997-08-01), Calhoun et al.
patent: 5661132 (1997-08-01), Eriksson et al.
patent: 5697901 (1997-12-01), Eriksson
patent: 5733761 (1998-03-01), Treco et al.
patent: 5750376 (1998-05-01), Weiss et al.
patent: 5770405 (1998-06-01), Wong-Madden et al.
patent: 5780014 (1998-07-01), Eljamal et al.
patent: 5780045 (1998-07-01), McQuinn et al.
patent: 5789247 (1998-08-01), Ballay et al.
patent: 5798113 (1998-08-01), Dionne et al.
patent: 5804413 (1998-09-01), DeLuca
patent: 5814607 (1998-09-01), Patton
patent: 5834251 (1998-11-01), Maras et al.
patent: 5858751 (1999-01-01), Paulson et al.
patent: 6083725 (2000-07-01), Selden et al.
patent: 6410272 (2002-06-01), Meyhack et al.
patent: 6458574 (2002-10-01), Selden
patent: 6566099 (2003-05-01), Selden et al.
patent: 6607901 (2003-08-01), Schaffer et al.
patent: 2003/0049245 (2003-03-01), Mann et al.
patent: A21796/88 (1988-09-01), None
patent: B-21796/88 (1989-03-01), None
patent: 0 307 285 (1989-03-01), None
patent: 0 307 285 (1989-03-01), None
patent: 0 307 285 (1989-03-01), None
patent: 0 408 461 (1991-01-01), None
patent: A H01-165373 (1989-06-01), None
patent: H03-143393 (1991-06-01), None
patent: A H06-503479 (1994-04-01), None
patent: A H08-503615 (1996-04-01), None
patent: WO 90/11353 (1990-10-01), None
patent: WO 92/13067 (1992-01-01), None
patent: WO-9213067 (1992-01-01), None
patent: WO 92/06187 (1992-04-01), None
patent: WO 93/08292 (1993-04-01), None
patent: WO 93/09222 (1993-05-01), None
patent: WO 94/12628 (1994-06-01), None
patent: WO 95/06478 (1995-03-01), None
patent: WO 98/11206 (1998-03-01), None
Hsiung et al., Biotechnology, vol. 4, pp. 991-995 (1986).
Selden et al., Molecular & Cellular biology, vol. 6, pp. 3173-3179 (1986).
Misra-Press et al., J. Biol. Chem., vol. 269, pp. 23,220-223,229 (1994).
Pecceu et al., “Human interleukin 1β fused to the human growth hormone signal peptide is N-glycosylated and secreted by Chinese hamster ovary cells”, Gene, vol. 97, pp. 253-258, (1991).
Calhoun et al., “Fabry disease: Isolation of a cDNA clone encoding human α-galactosidase A”, Proc. Natl. Acad. Sci. USA, vol. 82, pp. 7364-7368 (1985).
Bishop et al., “Affinity Purification of α-Galactosidase A from Human Spleen, Placenta, and Plasma with Elimination of Pyrogen Contamination”, The Journal of Biological Chemistry, vol. 256(3), pp. 1307-1316 (1981).
Medin et al., “Correction in trans for Fabry disease: Expression, secretion, and uptake of α-galactosidase A in patient-derived cells driven by a high-titer recombinant retroviral vector”, Proc. Natl. Acad. Sci. USA, vol. 93, pp. 7917-7922 (1996).
English Abstract of JP-A H01-165373 (MicroPatent Reference No. 002598242).
Beutler, “Gaucher's Disease”, New Engl. J. Med. 325: 1354-1360 (1991).
Cuozzo et al., “Lysine-based Structure Responsible for Selective Mannose Phosphorylation of Cathespin D and Cathespin L Defines a Common Structural Motif for Lysosomal Enzyme Targeting”, J. Biol. Chem. 273: 1069-21076 (1998).
Delgado et al., “The Uses and Properties of PEG-Linked Proteins”, Crit. Rev. Ther. Drug Carrier Syst. 9: 249-304 (1992).
Desnick et al., “α-Galactosidase A Deficiency: Fabry Disease: The Metobolic and Molecular Basis of Inherited Disase”, Chapter 889, pp. 2741-2784.
Desnick et al., “Enzyme Therapy XVII: Metabolic and Immunologic Evaluation of α-Galactosidase A Replacement in Fabry Disease”, Birth Defects, vol. 16(1), pp. 393-413 (1980).
Diment et al., “Generation of Macrophage Variants With 5-Azacytidine: Selection for Mannose Receptor Expression”, J. Leukocyte Biol. 41: 485-490 (1987).
Edwards et al., “Large Porous Particles for Pulmonary Drug Discovery”, Science 276: 1868-1872 (1997).
Eng et al., “Safety and Efficacy of Recombinant Human . . . ”, N Engl J Med. 2001 ,Jd5; 345(1): 9.
Eng et al., “A Phase 1/2 Clinical Trail of Enzyme . . . ”, Am J Hum Genet Mar. 2001; 68(3): 71 1.
Francis et al., “PEGlyation of cytokines and other therapeutic proteins and peptides: the importance of biological optimisation of coupling techniques”, Int. J. Hematol 68(1):1-18 (1998).
Garman et al., “The Molecular Defect Leading to Fabry Disease: Structure of Human α-Galactosidase”, J. Mol. Biol., vol. 337, pp. 319-335 (2004).
Grammatikos et al, “Intercellular UDP-N-Acetylhexosamine Pool AffectN-Glycan Complexity : A Mechanism of Ammonium Action on Protein Glycosylation”, Biotechnol. Prog. 14: 410-419 (1998).
Hantzopolous et al., “Expression of the human α-galactosidase A inEscherichia coliK-12”, Gene, 57: 159 (1987).
Hermentin et al., “The hypothetical N-glycan charge: a number that characterizes protein glycosylation”, Glycobiology 6:217-230 (1996).
Hokke et al., “Sialylated carbohydraft chains of recombinant human glycoproteins expressed in Chinese hamster ovary cells contain trace of N-glyoulmeruaminic acid”, Federation of European Biochemical Societies, vol. 27, No. 1, 2, pp. 9-14, (1990).
Ihara et al, “cDNA Cloning, Expression, and Chromosomal Localization of Human N-Acetylglucosaminyltransferase III (Gn-T-111)1”, J. Biochem. (Tokyo) 113: 692-698 (1993).
Isidoro et al., “Suppression of the ‘uncoverage’ of mannose-6-phosphate residues in lysosomal enzymes in the presence of NH4Cl”, Eur. J. Biochem. 191: :591-597 (1990).
Jenkins et al., “Getting the glycosylation right: Implications for the biotechnology industry”, Nature Biotechnology, vol. 14, pp. 975-981 (1996).
Kinstler et al., “Characterization and Stablity of N-terminally PEGylated rhG-CSF”, Pharn. Res. 13:996-1002 (1996).
Körner et al., “Carbohydrate-deficient glycoprotein syndrome type V: Deficiency of dolichyl-P-Glc:Man9Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase”, Proc. Natl. Acad. Sci. USA 95:13200-13205 (1998).
Kornfeld & Mellman, “Annual Review of Cell Biology: The Biogenesis of Lysosomes” 5:483-525 (1989).
Kukuruzinska & Lennon, “Protein N-Glycosylation: Molecular Genetics and Functional Significance”, Crit. Rev. Oral. BioL Mad. 9: 415-48 (1998).
LeDonne et al., “Biosynthesis of α-Galactosidase A in Cultured Change Liver Cells1”, Arch. Biochem. Biophys.114: 186 (1983).
Lee et al., “A biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry disease”, Glycobiology, vol. 13, No. 4, pp. 305-313 (2003).
Marikar et al., “Leaching of Concanavalin A during Affinity Chromatographic Isolation of Cell Surface Glycoproteins from Human Fetal Neurons and Glial Cells”, Anal Biochem. 201: 306-310 (1992).
Matsuura et al., “Human α-galactosidase A: characterization of the N-linked oligosaccharides on the intraceullular and secreted glycoforms overexpressed by Chinese hamster ovary cells”, Glycobiology 8:329-339 (1998).
Mizushima et al., “pEF-BOS, a powerful mammalian expression vector”, Nucl. Acids Res. 18:5322 (1990).
Nakao et al., “An atypical Variant of Fabry's Disease in Men with Left Ventricular Hypertrophy”, New Engl. J. Mod. 333: 288-293 (1995).
Rijcken et al., “The effect of increasing nucleotide-sugar concentrations on the incorporation of sugars into glycoconjugates in

Affiliated with

Also associated with

Rating

Nucleic acid encoding a chimeric polypeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acid encoding a chimeric polypeptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid encoding a chimeric polypeptide will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3686404